Chemotherapy for ovarian cancer - a consensus statement on standard practice

This publication has 12 references indexed in Scilit:

• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience
  British Journal of Cancer, 1995
• Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
  Journal of Clinical Oncology, 1994
• Management of ovarian cancer: referral to a multidisciplinary team matters
  British Journal of Cancer, 1994
• Paclitaxel (Taxol) treatment for refractory ovarian cancer: Phase II clinical trial
  American Journal of Obstetrics and Gynecology, 1994
• Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.
  Journal of Clinical Oncology, 1993
• Advanced epithelial ovarian cancer: 1993 consensus statements
  Annals of Oncology, 1993
• Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
  Journal of Clinical Oncology, 1991
• Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds
  Gynecologic Oncology, 1990
• Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials
  British Journal of Cancer, 1989